[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368463-105":59,"doc-detail-368463-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","chemoprevention-of-gastrointestinal-cancers-an-umbrella-review-of-meta-analyses-of-randomized-controlled-trials-and-cohort-studies","Chemoprevention of Gastrointestinal Cancers - An Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Cohort Studies","","Several meta-analyses have examined how chemopreventive agents (CPAs) relate to gastrointestinal cancer risk, yet integrated assessments of evidence quality across studies remain insufficient. This umbrella review evaluated the credibility of evidence from meta-analyses of RCTs and cohort studies assessing inverse CPA–gastrointestinal cancer associations. Eligibility screening from 20,296 publications yielded 69 articles containing 194 unique meta-analyses. Among RCT meta-analyses, 26 were significant and selected inverse associations were graded as high or moderate quality; among cohort meta-analyses, 60 were significant with convincing or highly suggestive findings in specific CPA–cancer pairs. Overall, consistent evidence targeted established progression risk factors, and limited evidence suggested further study for metformin and statins.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemoprevention-of-gastrointestinal-cancers-an-umbrella-review-of-meta-analyses-of-randomized-controlled-trials-and-cohort-studies/368463/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemoprevention-of-gastrointestinal-cancers-an-umbrella-review-of-meta-analyses-of-randomized-controlled-trials-and-cohort-studies/368463.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of this umbrella review?","Question",{"text":113,"@type":114},"To assess the quality/credibility of evidence from meta-analyses of randomized controlled trials and cohort studies examining inverse associations between chemopreventive agents and gastrointestinal cancer risk or premalignant conditions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many publications and meta-analyses were included?",{"text":118,"@type":114},"From 20,296 publications, 577 full-text articles were screened, and 69 articles were included, providing 194 unique meta-analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"Which chemopreventive associations were graded as high-quality or moderate among RCT meta-analyses?",{"text":122,"@type":114},"Celecoxib and colorectal adenomas were graded as high quality, while aspirin and colorectal adenomas and H-pylori eradication and gastric cancer were graded as moderate.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368463,1790437156,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Clinical and Translational Science   \n SYSTEMATIC REVIEW  OPEN ACCESS   \nChemoprevention of Gastrointestinal Cancers: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Cohort Studies  \nJia En Chan1  | Suresh Shanmugham1  | Suresh Kumar1  | Yeong Yeh Lee2,3  | Siew Mooi Ching4,5,6  | Nathorn Chaiyakunapruk7,8,9  | Sajesh K. Veettil1,10   \n1Department of Pharmacy Practice, School of Pharmacy, IMU University, Kuala Lumpur, Malaysia | 2School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia | 3GI Function and Motility Unit, Hospital USM, Universiti Sains Malaysia, Kota Bharu, Malaysia | 4Faculty of Medicine and Health Sciences, Department of Family Medicine, Universiti Putra Malaysia, Seri Kembangan, Malaysia | 5Malaysian Research Institute on Ageing, Universiti Putra Malaysia, Serdang, Malaysia | 6Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia | 7Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA | 8IDEAS Centre, Veterans Affairs Salt Lake  \nCity Healthcare System, Salt Lake City, Utah, USA | 9School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia | 10School of Medicine, Taylor's University, Petaling Jaya, Selangor, Malaysia  \nCorrespondence: Nathorn Chaiyakunapruk ([nathorn.chaiyakunapruk@utah.edu](nathorn.chaiyakunapruk@utah.edu)) | Sajesh K. Veettil ([sajeshveettil@imu.edu.my](sajeshveettil@imu.edu.my))  \nReceived: 18 November 2024 | Revised: 2 April 2025 | Accepted: 14 April 2025  \nFunding: The authors received no specific funding for this work.  \nKeywords: chemoprevention | cohort studies | gastrointestinal cancers | meta-analysis | randomized controlled trial | umbrella review  \nABSTRACT  \nSeveral meta-analyses have investigated the association between chemopreventive agents (CPAs) and the risk of gastrointestinal cancers, but syntheses of the quality of evidence in aggregate are lacking. This umbrella review aimed to assess the quality of evidence from meta-analyses of randomized controlled trials (RCTs) and cohort studies that examine inverse associations between CPAs and the risk of gastrointestinal cancers or any premalignant conditions. Summary effect sizes from random-effects models, between-study heterogeneity, 95% prediction interval, small-study effect, excess significance, and credibility ceilings were devised to classify the credibility of evidence from meta-analyses of cohort studies, whereas the GRADE approach was used for meta-analyses of RCTs. From 20,296 publications, 577 full-text articles were evaluated for eligibility, and 69 articles that provided 194 unique meta-analyses were included. Among meta-analyses of RCTs (N = 93), 26 reached statistical significance (p \u003C 0.05). Seven inverse associations were graded as either high quality (celecoxib and colorectal adenomas,(N = 4)) or moderate (aspirin and colorectal adenomas,(N = 2) and H-pylori eradication and gastric cancer (N = 1)). Among meta-analyses of cohort studies (N = 101), 60 reached statistical significance. Four inverse associations were graded as either convincing (antivirals with hepatocellular carcinoma (HCC); N = 1) or highly suggestive (aspirin with HCC (N = 2) and colorectal cancer (N = 1)) . This review suggests that the associations with the most consistent empirical evidence were confined to those targeting the wellestablished risk factors of gastrointestinal cancer progression. Despite the limited established evidence, the inverse associations observed between metformin and colorectal, esophageal, and gastric cancers, as well as between statins and HCC and gastric cancer, merit further research.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are mad","cbCaidUvTN1Y57ff","https://ap.wps.com/l/cbCaidUvTN1Y57ff","pdf",424871,17,"English","# Summary\n# What is the current knowledge on the topic?\n# What question did this study address?\n# What does this study add to our knowledge?\n# How might this change clinical pharmacology or translational science?","[{\"question\":\"What was the purpose of this umbrella review?\",\"answer\":\"To assess the quality/credibility of evidence from meta-analyses of randomized controlled trials and cohort studies examining inverse associations between chemopreventive agents and gastrointestinal cancer risk or premalignant conditions.\"},{\"question\":\"How many publications and meta-analyses were included?\",\"answer\":\"From 20,296 publications, 577 full-text articles were screened, and 69 articles were included, providing 194 unique meta-analyses.\"},{\"question\":\"Which chemopreventive associations were graded as high-quality or moderate among RCT meta-analyses?\",\"answer\":\"Celecoxib and colorectal adenomas were graded as high quality, while aspirin and colorectal adenomas and H-pylori eradication and gastric cancer were graded as moderate.\"}]","Chemoprevention of Gastrointestinal Cancers - An Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Cohort Studies | PDF",1790177057,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94c168a4a9c4c8e4316775ac46bba369.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b05c22f06fdaae25835e6a9b506ff37.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/317e189e56e7278baa9fde5e4d62af54.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f74741cf1eee3ecc9ad66f6c2685b52e.webp",980,1287]